US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs Market Research Reports & Industry Analysis

RSS Feeds

Prescription Drugs Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Pharmaceuticals and Healthcare Report - United Arab Emirates Q4 2014
10/8/2014 | published by: Business Monitor International
... the four northern emirates (Ras al-Khalmah,Ajman, Fujairah and Umm al-Quwain) will receive a welcome boost from significant investment andgovernment spending plans. One downside risk is that state intervention in drug pricing is set to becomemore ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Uzbekistan Q4 2014
10/8/2014 | published by: Business Monitor International
... bymounting spending in medical technologies and equipment on the back of the upgrading and construction ofhealthcare facilities. Increasing pharmaceutical demand has also been driven by private consumptiongrowth and rising exports to neighbouring countries. Meanwhile, the ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Denmark Q4 2014
10/15/2014 | published by: Business Monitor International
... driven by its expanding aging population. However, this willsee the government continue to target the healthcare sector with cost-containment measures. Despite this,we believe Denmark will remain an attractive market for drugmakers to operate in due ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Oman Q4 2014
10/15/2014 | published by: Business Monitor International
... Increasing infrastructure, a higherhealthcare budget and an enhanced potential for medical tourism are all positive developments this quarter. Stable political and economic environments are also attractive features of this market. Headline Expenditure Projections Pharmaceuticals: OMR187mn ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Czech Republic Q4 2014
10/15/2014 | published by: Business Monitor International
... larger multinationals with competitive pressures expected tocontinue to favour those with scale. While we expect the Czech market to stabilise in 2014, we note thatdepreciatory pressure on the Czech koruna could see incomes decline for ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Finland Q4 2104
10/15/2014 | published by: Business Monitor International
... we believe this will result in stronger downward price pressures onmedicines that treat long-term chronic diseases, with companies increasingly being required to prove thecost-effectiveness of innovative medicines in order to gain reimbursement. Headline Expenditure Projections ...  |  read more...
USD 1,295
Zimbabwe Pharmaceuticals and Healthcare Report Q4 2014
9/24/2014 | published by: Business Monitor International
... in themedium-to-long term. The already dire situation, in which the health service is heavily reliant on donations,lacks skilled workers and essential medicines, and the fact that the vast majority of the healthcare budget isnot even ...  |  read more...
USD 1,295
Online Pharmaceutical Sales in Australia - Industry Market Research Report
9/24/2014 | published by: IBISWorld
... dual presence (both physical stores and online operations). This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth ...  |  read more...
USD 965
Pharmacies in Australia - Industry Market Research Report
9/12/2014 | published by: IBISWorld
... pharmacy groups include independent community pharmacies, banner groups (both wholesaler-owned and independent), friendly societies, buying groups and discount pharmacies. This report covers the scope, size, disposition and growth of the industry including the key sensitivities ...  |  read more...
USD 965
Global Erectile Dysfunction Drugs Market : 2014-2018
9/10/2014 | published by: TechNavio - Infiniti Research Ltd.
... inconsistency to do so, or the inability to endure it for an extended period. Erectile dysfunction can be due to a number of reasons including aging, high blood pressure, diabetes mellitus, depression, smoking, nerve or ...  |  read more...
USD 2,500
Austria Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
... Commerce department has listed Austria as one of the most attractive countries in which to markethealthcare technologies, while one of its domestic pharmaceutical firms has announced success indeveloping a cure for Alzheimer's. We believe that ...  |  read more...
USD 1,295
Ireland Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
... new headquarters' domicile in Ireland,although the megatrend of consolidation within the pharmaceutical industry, including cross-bordermergers and redomiciling in Ireland for tax saving purposes, is expected to continue over the near term. More broadly, due to ...  |  read more...
USD 1,295
Myanmar Pharmaceuticals and Healthcare Report Q4 2014
9/17/2014 | published by: Business Monitor International
... the growth of theeconomy. Headline Expenditure Projections Pharmaceutical sales: MMK324.8bn (USD350mn) in 2013 to MMK387.5bn (USD390mn) in 2014;+19.3% in local currency terms and +11.3% in US dollar terms. Forecast unchanged from previousquarter. Healthcare Expenditure: MMK1,047.3bn ...  |  read more...
USD 1,295
Bulgaria Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... 2014 and 2015 forecasts. Bulgaria's positiveeconomic outlook in 2014/15 will provide a safety buffer, but structural issues within the country'shealthcare system will require legislative reform from the Bulgarian parliament. Headline Expenditure Projections Pharmaceuticals: BGN2.32bn (USD1.58bn) ...  |  read more...
USD 1,295
France Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... increaseits focus on cost containment within the pharmaceuticals and healthcare sector, with a particular focus onmedicine prices. Headline Expenditure Projections Pharmaceuticals: EUR33.94bn (USD44.80bn) in 2013 to EUR33.06bn (USD44.30bn) in 2014; -2.6% inlocal currency terms and ...  |  read more...
USD 1,295
Gabon Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... in poverty - especially in rural areas. Alleged corruption prevents a trickling down of oil revenues to the general population. After years ofplaying down the country's social problems, President Ali Bongo seems to have decided ...  |  read more...
USD 1,295
Lebanon Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... generic drugs,increased local production and using competition to lower prices will dramatically improve Lebanon'sprospects for foreign direct investment. However, further drug price reductions with the health minister'srecently amended pharmaceutical bill, along with the country's ongoing ...  |  read more...
USD 1,295
Poland Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... the pharmaceuticals sector. Despite negative regulatory constraints, we believe a large and aging population along with its associatedburden of disease will drive the demand for both patented and generic medicines in the future. We maintainour ...  |  read more...
USD 1,295
China Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... potential. However, over the long term, the government is likely to improve its investment in healthcare in order toretain public support. Headline Expenditure Projections Pharmaceuticals: CNY532.4bn (US$86.6bn) in 2013 to CNY616.1bn (US$99.3bn) in 2014; +15.7% ...  |  read more...
USD 1,295
Estonia Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... written. Privateconsumer spending will continue to bolster pharmaceutical sales in 2014 as wage growth continues. Despite this data, Estonia will continue to remain a marginal market in the Central and Eastern Europeanregion. Whether or not ...  |  read more...
USD 1,295
Peru Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... of foreign companies from the list of 'High Sanitary Surveillance' practicecountries. In addition, the relatively weak domestic pharmaceutical industry, the ongoing liberalisation ofbilateral trade agreements and healthcare reform, as well as Peru's investor-friendly business environment,will ...  |  read more...
USD 1,295
Puerto Rico Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... the US economy. Drugmakerscan also capitalise on the government's promotion of the local production of generic medicines and biologicdrugs. Headline Expenditure Projections Pharmaceuticals: USD3.02bn in 2013 to USD3.02bn in 2014; +0.2% in local currency terms. ...  |  read more...
USD 1,295
Botswana Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... developingpharmaceutical production within the country. Risks to our outlook include the continued presence ofcounterfeit pharmaceuticals and the forecast depreciation of the Botswana pula. Headline Expenditure Projections Pharmaceuticals: BWP1.62bn (USD193mn) in 2013 to BWP1.74bn (USD193mn) in ...  |  read more...
USD 1,295
Tanzania Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... especiallygiven spending levels in the previous fiscal year, and the fact that government expenditure tends to come inunder budget, in addition to the government's heavy reliance on aid. The country's rising population andincreasing urbanisation will ...  |  read more...
USD 1,295
Philippines Pharmaceuticals and Healthcare Report Q4 2014
9/24/2014 | published by: Business Monitor International
... investment and interest in the country's pharmaceutical market. Nevertheless, the government'sintention to improve healthcare through the implementation of a universal healthcare scheme will continueto present significant revenue-generating opportunities for firms over the long term. Headline ...  |  read more...
USD 1,295
  2    4  5  6  7  8  9  10